ADMA Biologics, Inc. (ADMA) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of ADMA Biologics, Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADMA
ADMA Biologics, Inc.
$10.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CLDX
Celldex Therapeutics, Inc.
$32.59HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADMA vs CLDX
growth of $100 · dividends reinvested · last 10yADMA +50.9% (+4.2%/yr)CLDX -49.1% (-6.5%/yr)ADMA compounded faster over this window
ADMA CLDX
ADMA vs CLDX: by the numbers
- •ADMA is the larger company ($2.34B vs $2.17B market cap).
- •ADMA is profitable (32.98% net margin) while CLDX runs a net loss (-268385.71%).
- •ADMA grew revenue faster over the past five years (54.55% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | ADMA | CLDX |
|---|---|---|
| P/E ratio | 14.44 | N/A |
| Forward P/E | 12.69 | N/A |
| P/S ratio | 4.57 | 19361.50 |
| P/B ratio | 5.74 | 3.03 |
| EV / EBITDA | 10.67 | N/A |
| FCF yield | 4.97% | N/A |
Profitability
| Metric | ADMA | CLDX |
|---|---|---|
| Gross margin | 64.71% | 100.00% |
| Operating margin | 42.26% | -19160.00% |
| Net margin | 32.98% | -268385.71% |
| ROE | 41.39% | -42.07% |
| ROIC | 27.60% | -45.19% |
Growth (annualized)
| Metric | ADMA | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | 54.55% | -58.05% |
| Total return CAGR (5Y) | 54.74% | -10.28% |
Frequently asked
- Which has grown faster, ADMA or CLDX?
- Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus CLDX at -58.05%.
- Is ADMA or CLDX more profitable?
- ADMA runs the higher net margin — ADMA at 32.98% versus CLDX at -268385.71%.
- How have ADMA and CLDX total returns compared?
- Over the past 10 years, ADMA delivered 3.85% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ADMA Biologics P/E ratioADMA Biologics ROECelldex Therapeutics ROEADMA Biologics operating marginCelldex Therapeutics operating marginADMA Biologics revenue growthCelldex Therapeutics revenue growthADMA Biologics free cash flowCelldex Therapeutics free cash flow
ADMA Biologics & Celldex Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.